Clover Health Investments Net Change in Short-term Investments 2020-2025 | CLOV
Clover Health Investments net change in short-term investments from 2020 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
| Clover Health Investments Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $141 |
| 2022 | $116 |
| 2021 | $-435 |
| 2020 | $N/A |
| 2019 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.623B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.830B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Schrodinger (SDGR) | United States | $1.570B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Omnicell (OMCL) | United States | $1.322B | 23.33 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Standard BioTools (LAB) | United States | $0.350B | 0.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |